wheeze/asthma" associated with persistent wheezing at any age and with Background -There is increasing evidence methacholine hyperresponsiveness, peak that wheezing during childhood may be a flow variability, and markers of atopy. heterogeneous condition, and that differ- (Thorax 1997;52:946-952) ent forms of wheezing may be associated with different risk factors and prognosis. Keywords: methacholine, peak flow, atopy, wheezing, The aim of this study was to determine if children. measures of airway lability and of atopy could identify distinct wheezing phenoThere is increasing evidence to suggest that types during childhood.
years of life and unrelated to increased population sample followed from birth. airway lability; "non-atopic wheezing" of 1984 as part of the Tucson Children's Res-least one PEF value exceeding 30% of the daily mean. 12 20 Results using this 30% amplitude piratory Study (CRS) . 17 A total of 1246 children were initially enrolled. Details on data index were not different from those obtained using the Amp%mean and for this reason only collection and procedures are presented elsewhere. 17 18 the latter results are presented here.
Because at the time the study was designed During the first three years of life parents were instructed to see their paediatricians there were concerns regarding parental acceptability and safety of the methacholine chalwhenever their children presented with signs or symptoms of lower respiratory tract illness. lenge for symptomatic patients, children who had used asthma medications in the previous When children reached a mean (SD) age of 6.3 (0.9) years ("age 6", n=1024) and 10.9 three months were excluded from methacholine testing. Children who had had an upper res-(0.6) years ("age 11", n=956) the parents completed questionnaires regarding their chil-piratory infection in the previous four weeks or a lower respiratory infection in the previous dren's respiratory symptoms. For both the age 6 and age 11 surveys wheeze was defined as six weeks, those with cardiac problems, other systemic diseases, or with reactions such as parental reporting of any wheezing episode in the previous 12 months, regardless of a dia-severe headaches were also excluded. Challenges were performed using the protocol degnosis of asthma. To assess the association of measurements of airway lability with persistent scribed by Yan et al 21 with nebulised cumulative doses of methacholine ranging from 0.004 to or remitting wheezing, subjects were classified according to their wheezing status at ages <3 2.048 mg.
Results for methacholine challenge were exand 6 years and then at ages 6 and 11 years.
The study was approved by the Human Sub-pressed as the methacholine-DRS. The end point was defined as a 20% fall in forced exjects Committee at the University of Arizona. Parents signed separate consent forms for the piratory volume in one second (FEV 1 ) from baseline or FEV 1 at the final cumulative dose initial enrolment of the infants and for other studies described in this paper. of 2.048 mg. The response was calculated as the two point slope between baseline and end point FEV 1 per log dose 9 :        methacholine-DRS= A total of 754 children were still living in Tucson at the time of the age 11 survey. Of (last FEV 1 − baseline FEV 1 ) log last dose these, a total of 676 children took home peak flow meters to measure peak flow (PEF) three times daily for one week. Children and their
We defined bronchial hyperresponsiveness parents were trained by study nurses on the as methacholine-DRS values below the 10th use of the PEF meter. Subjects were asked to percentile of the methacholine-DRS disrecord on a diary the best of three attempts tribution for a healthy reference subgroup (as after waking up in the morning, when they defined for the PEF group, n=100). The came home from school in the afternoon, and methacholine response was also determined by before going to bed at night. To assess the the PD 20 , as described previously. 22 Results "learning effect" on PEF measurements we using PD 20 were not different from those of the tested Cochran's Q 19 using all three sessions methacholine-DRS index and therefore will not for the seven day period. Only measures from be presented in this paper. the first morning of the study were found to be lacking homogeneity with the rest of the week's values and were thus eliminated from the analysis. Only children who recorded PEF      measurements at least twice per day (after elimSkin prick tests were performed using extracts ination of measures from the first morning of of common allergens in the Tucson area. At the study) for at least 4 days were included in six years of age house dust, bermuda grass, the analysis. 16 olive, careless weed, alternaria, mesquite, and The amplitude percent mean (Amp%mean) mulberry were used and at age 11 Dermawas chosen as the peak flow variability index 15 19 tophagoides farinae and cat dander were added and defined as:
(allergens provided by Holister-Stier Laboratories, Everett, Washington, USA). Skin test Amp%mean= positive subjects were defined as those who
(maximum daily PEF -minimum daily PEF)/mean daily PEF number of days in the period ×100
had at least one positive reaction (weal size measuring 3 mm or more after subtraction of the control value) in either of the two surveys Positive peak flow variability was considered to be present in subjects with Amp%mean in which they were performed.
Blood for serum IgE analysis was obtained values above the 90th percentile for a healthy reference subgroup (subjects who were skin at birth from the umbilical cord, at a median age of 9.3 months (the "9 month" sample), test negative, had never wheezed, nor had been diagnosed as having asthma, n=136). To val-and again at ages 6 and 11. Total serum IgE levels were measured with paper radioimmunoidate the Amp%mean variable and cut off level better we also assessed an index of PEF vari-sorbent test (Pharmacia Diagnostics, Piscataway, New Jersey, USA).
for peak flow variability or for methacholine- three months from the methacholine group. Baseline FEV 1 at age 11 was similar for children who performed either PEF or methacholine   challenge tests. The children in the group that Contingency tables and the 2 distribution were performed no tests were slightly older. There used for bivariate analysis and logistic re-were 711 children who had allergy skin tests in gression for multivariate evaluation of di-both surveys, 68% of whom had at least one chotomous outcome data. The 95% confidence positive skin test. intervals (CI) for odds ratios were calculated with standard algorithms. The continuous distribution of IgE levels at each survey was cate-%  -   gorised in quartiles and assessed for relation  with Amp%mean and methacholine-DRS Subjects were classified as having positive peak using a 2 for trend test. Statistical significance flow variability if Amp%mean values were was defined by a two-sided alpha level of 0.05.
greater than or equal to the cut off value of 16.6% (the 90th percentile for the healthy reference population sample). Among children Results who performed methacholine challenge, those   who had a coefficient less than or equal to Of the 655 children contacted for methacholine −0.403 ml/log dose unit represented the lower testing, 213 were excluded (78 because of the 10th percentile and were thus defined as having use of asthma medications in the previous three methacholine hyperresponsiveness. months, 93 because they refused or missed the appointment, and 42 because of infections of the upper or lower respiratory tracts in the previous weeks, headaches, congenital prob-       lems, or other associated diseases) and 45 had poor test performance, leaving 397 subjects     11     ,   ,   with valid tests. Of the 676 children who were sent home with PEF meters, diaries were re-Bivariate analysis (table 2) showed that children who had positive peak flow variability at age covered from 664, of which 64 had inadequate or insufficient data. A total of 350 children had 11 were almost twice as likely to have wheezed at age <3 compared with children who did not both valid PEF measures and methacholine challenge tests; 303 children had no data either wheeze at that age (odds ratio (OR) 1.9 (95% flow variability (table 3) . In contrast, metha- * * * pΖ0.001; * * pΖ0.01; * pΖ0.05.
choline hyperresponsiveness at age 11 was as- † OR (odds ratio) and 95% CI (95% confidence interval). † † URIs=upper resoiratory infections at age 11; subjects with URIs were excluded from methasociated with wheezing at age 11 (OR 3.2 (95% choline challenge. CI 1.7 to 5.9), p<0.001), positive skin test results (OR 3.0 (95% CI 1.6 to 5.6), p<0.001), and with the male sex (OR 2.1 (95% CI 1.2 to 3.5), p<0.05). Methacholine hyper-CI 1.1 to 3.3), p<0.05). There was also a responsiveness at age 11 showed no association significant association between positive peak with wheeze at ages <3 or 6 years. flow variability and wheeze at age 6 (OR 2.0 (95% CI 1.1 to 3.4), p<0.01) but not with wheeze at age 11. Fifty seven children among those who performed PEF tests at age 11 had upper respiratory tract infections in the pre-       vious four weeks (there were no children with lower respiratory tract infections among those     11      3  6 who performed PEF tests). Children with upper respiratory tract infection at the time of Children were assigned to four groups according to their wheezing status during the first the age 11 survey had a significantly higher prevalence of positive peak flow variability at six years of life (table 4), as described in our previous study. 2 Neither positive peak flow varithat age (OR 2.1 (95% CI 1.0 to 4.5), p<0.05) than those without upper respiratory tract in-ability nor methacholine hyperresponsiveness at age 11 were associated with "transient early fections. Neither sex nor positive skin tests to allergens were associated with peak flow wheezing" -that is, wheezing during the first three years of life but no wheezing at six years variability. In contrast, positive methacholine was associated with wheeze at age 11 (OR 4.4 of age. Positive peak flow variability at age 11 years was significantly associated with wheezing (95% CI 2.6 to 7.4), p<0.001) but not with wheeze at ages 6 or <3 years. There was also at age 6 (skin test negative subjects who wheezed at age 6 but not at age 3 (OR 3.3 a fourfold increased risk of being methacholine positive for skin test positive subjects compared (95% CI 1.0 to 12.5), p<0.05), and skin test positive subjects who were wheezing at both with those who were skin test negative (OR 4.3 (95% CI 2.4 to 7.8), p<0.001). Boys were at a surveys (OR 3.3 (95% CI 1.3 to 8.8), p<0.01)).
Methacholine hyperresponsiveness at age 11 significantly higher risk of having methacholine hyperresponsiveness than girls (OR 2.3 (95% was unrelated to any of the groups of wheezers up to age 6, although there was a marginal CI 1.4 to 3.7), p<0.001).
Logistic regression analysis (table 3) , with association for subjects who were wheezing both at ages 3 and 6 among those who were methacholine hyperresponsiveness and positive peak flow variability measured at age 11 as the skin test positive. 4.5 (2.0 to 10.1) * * * 1.9 (0.9 to 4.4) * * * pΖ0.001; * * pΖ0.01; * pΖ0.05. † OR (odds ratio) and 95% CI (95% confidence interval) adjusted by sex and for URIs. † † No wheeze both at age 6 and 11 (no wheeze at 6/no wheeze at 11); wheezing by age 6 and no wheezing at age 11 (yes wheeze at 6/no wheeze at 11); no wheezing at age 6 and wheezing at age 11 (no wheeze at 6/yes wheeze at 11); and wheezing both at age 6 and 11 (yes wheeze at 6/yes wheeze at 11). † † † Total number of subjects is greater than subtotals for skin test positive and skin test negative subjects because some subjects did not have skin test results. ‡ Reference odds ratio.
  
who had positive peak flow variability at age 11 and were skin test negative were also at an         11   increased risk of having wheezed at age 6 but not at 11 (OR 2.9 (95% CI 1.0 to 8.8), pΖ0.05    6  11 Children were also grouped according to their for yes wheeze at 6/no wheeze at 11). wheezing status at ages 6 and 11 (table 5) . Children who had methacholine hyperresponsiveness at age 11 and were skin test positive were more likely to be wheezing at age        11 irrespective of wheezing at age 6 (OR 2.5 (95% CI 1.1 to 5.7), p<0.05 and 4.5 (95% CI     11    IE     2.0 to 10.1), p<0.001 for no wheeze at 6/yes wheeze at 11 and yes wheeze at 6/yes wheeze Positive peak flow variability at age 11 was not found to be related to high serum IgE levels in at 11, respectively). In addition, positive peak flow variability at age 11 was significantly as-any of the surveys at which this variable was assessed (fig 1) . In contrast, methacholine sociated with persistent wheezing (OR 2.3 (95% CI 1.2 to 4.5), pΖ0.01 for yes wheeze hyperresponsiveness at age 11 was marginally correlated with log total serum IgE levels at 6/yes wheeze at 11). Conversely, children group.bmj.com on December 30, 2017 -Published by http://thorax.bmj.com/ Downloaded from Our data do not allow us to define the nature of the alteration in airway dynamics that was present in the non-atopic subjects who had positive peak flow variability at age 11, wheezing around the age of 6, but who were not wheezing at age 11. Peak flow variability was unrelated to skin test reactivity to allergens measured at ages 6 and 11 and to serum IgE levels measured in cord blood and at ages 9 months, 6 years, and 11 years. Conversely, methacholine responsiveness was strongly associated with skin test reactivity to allergens and with total serum IgE levels as measured both concurrently with methacholine measurements and five years earlier at age 6 (fig 1) . It thus appears that methacholine responsiveness and peak flow variability identify different types of abnormal airway behaviour.
13 This is in agreement with earlier findings by Siersted et al 19 25 who reported that some children with asthma related symptoms but no asthma dia- syndrome of less persistent wheezing through mechanisms which regulate airway tone independently of IgE mediated inflammation. We have previously reported that the main (p=0.07) at birth and highly correlated with serum IgE levels measured at ages 6 (p<0.001) risk factor for transient early wheezing (wheezing up to age 3 but not after) is a lower level of and 11 (p<0.0001).
airway function which can already be detected shortly after birth, 26 tracks along individual "growth curves", and remains low at age 6.
27

Discussion
Both methacholine hyperresponsiveness and In the present study we observed that this same group of children showed no increased positive peak flow variability when measured at age 11 were associated with persistent wheezing prevalence of methacholine hyperresponsiveness or positive peak flow variability, both measduring the school years (ages 6 and 11). Increased prevalence of positive peak flow vari-ured at age 11. It thus appears that increased airway lability is not the main factor responsible ability was also observed in a group of children who wheezed at age 6 but not at age 11 and who for the lower levels of lung function observed in these children. The decreased lung function were predominantly non-atopic. Methacholine hyperresponsiveness was associated with wheez-is more likely to be the consequence of mechanical characteristics of the lung such as altered ing at age 11 among atopic subjects, independent of wheezing at age 6. Two previous airway resistance or increased dynamic compliance. 28 As in our population, Stick et al 29 studies 8 24 that examined bronchial responsiveness in wheezing children of 4-6 years showed that children who wheezed in early life had lower levels of lung function than children of age reported that these children did not show the expected response to airway challenge tests who did not wheeze, but that bronchial responsiveness to histamine challenge was not as reported in older wheezing children or adults. Wilson et al 8 speculated that many pre-different between these two groups.
There are some limitations in our study that school wheezers do not have the same kind of atopy-related inflammatory airway response need to be addressed. We did not perform methacholine tests in children with a history of which is characteristic of older asthmatic subjects. This notion is supported by our findings significant asthma symptoms in the previous three months. More recent data suggest that of different patterns of response for peak flow variability and methacholine challenge when this precaution may have overestimated the possible side effects of methacholine challenge measured at the age of 11 years. Our data thus confirm the clinical impression that a con-in children with active asthma. The main consequence of this restriction was that a subset siderable number of children who wheeze during the toddler and early school years have a of more severely ill wheezers (n=78) were underrepresented in the sample of children condition that may be different from that of the classical, atopy-related asthma seen in older challenged with methacholine (table 1) . A close analysis of the possible consequences of this children or adults. Our findings and those of Wilson et al 8 have important consequences for restriction on our results suggests that our conclusions would not have changed had we inour understanding of childhood wheezing which appears to be a heterogeneous group cluded the subjects with more recent wheezing symptoms in our study. Indeed, the associations of conditions with a common final pathway represented by recurrent airway obstruction.
between methacholine and wheeze at age 11, were not wheezing at age 11 so the low pre-13 Brand PLP, Postma DS, Kerstjens HAM, Koetner GH, and the Dutch CNSLD study group. Relationship of airway valence of positive methacholine tests in this hyperresponsiveness to respiratory symptoms and diurnal group cannot be explained by selection bias. 
